SCHEMBL25015847

SCHEMBL25015847

N=C(N)c1ccc2cc(C(=O)Nc3ccc(N4CCCCC4)cc3)n(Cc3ccc(C(N)=O)cc3)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLG P00747 4/20 0.47
▸ PLAU P00749 4/20 0.47
▸ KLKB1 P03952 4/20 0.47
▸ PRSS1 P07477 4/20 0.47
▸ F2 P00734 3/20 0.47
▸ NPC1 O15118 7/20 0.45
▸ RAB9A P51151 7/20 0.45
▸ SMN1; SMN2 Q16637 5/20 0.45
▸ KMT2A Q03164 5/20 0.45
▸ MAPT P10636 4/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ MCL1 Q07820 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ F10 P00742 7/20 0.44
▸ PLAT P00750 3/20 0.44
▸ TP53 P04637 2/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25015851 0.99 PLG (0.47) PLGPLAUKLKB1PRSS1F2
SCHEMBL25015709 0.90 PLAU (0.49) PLGPLAUKLKB1PRSS1F2
SCHEMBL21822273 0.90 NPC1 (0.43) PLGPLAUKLKB1PRSS1F2
SCHEMBL21822390 0.89 RAB9A (0.45) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL21822393 0.89 RAB9A (0.45) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL25016691 0.89 RAB9A (0.45) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL25017267 0.88 PRSS1 (0.47) PLGPLAUKLKB1PRSS1F2
SCHEMBL25016161 0.88 F10 (0.58) KLKB1F2F10
SCHEMBL25016067 0.88 KMT2A (0.44) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL30180643 0.88 KMT2A (0.44) NPC1RAB9ASMN1; SMN2KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 PLG 225/4885PLAU 93/4885KLKB1 149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback